Cargando…
Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
Actinic keratoses (AKs) are epidermal cutaneous neoplasia observed predominantly in middle-aged and older subjects with mainly photo type I and photo type II on sun-exposed surfaces as a result of DNA damage. AKs have historically been characterized as being “precancerous”; however, now it is consid...
Autores principales: | Skroza, Nevena, Bernardini, Nicoletta, Proietti, Ilaria, Potenza, Concetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174892/ https://www.ncbi.nlm.nih.gov/pubmed/30323610 http://dx.doi.org/10.2147/TCRM.S145779 |
Ejemplares similares
-
Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017) -
Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013) -
Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
por: Lesiak, Aleksandra, et al.
Publicado: (2019) -
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012) -
Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017)